You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 9, 2025

List of Excipients in API chlorpheniramine maleate, ibuprofen, phenylephrine hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing chlorpheniramine maleate, ibuprofen, phenylephrine hydrochloride

Glossary

Detailed excipient profiles for chlorpheniramine maleate, ibuprofen, phenylephrine hydrochloride

Excipient focus: ACESULFAME POTASSIUM

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

chlorpheniramine maleate, ibuprofen, phenylephrine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE

Glossary
CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: HYPROMELLOSE

Excipient focus: LACTIC ACID

Excipient focus: MALTODEXTRIN

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

chlorpheniramine maleate, ibuprofen, phenylephrine hydrochloride drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES

Glossary
CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: POLYDEXTROSE

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: PROPYL GALLATE

Excipient focus: SILICON DIOXIDE

Excipient focus: STARCH, CORN

Excipient focus: SUCRALOSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group